Raltegravir-d3 Potassium Salt

• Catalog No.: R100302
• M. F.: C20H20FKN6O5
• M. W.: 482.5067032
• Storage: -20°C Freezer

SYNONYMS

• IUPAC name: potassium 4-{[(4-fluorophenyl)methyl]carbamoyl}-1-(^2H₃)methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate
• IUPAC Traditional name: potassium 4-{[(4-fluorophenyl)methyl]carbamoyl}-1-(^2H₃)methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxopyrimidin-5-olate
• Synonyms: N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-d3 Potassium Salt

PROPERTIES

• Storage Condition: -20°C Freezer
• Apperance: Off-White to Pale Yellow Solid
• Melting Point: 160-164°C
• Solubility: DMSO
• Solubility: Methanol

DETAILS

Description (English)

A potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug.

REFERENCES

• Wade, K., et al.: J. Pharmacol. Biomed. Anal., 8, 401 (1990)
• Hazuda, D., et al.: Science, 287, 646 (1990)
• Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (1990)
• Duckett, C., et al.: Xenobiotica, 36, 59 (1990)
• Miners, J., et al.: Biochem. Pharmacol